MIRENA 52 MG
LEVONORGESTREL : 52 MG · DIN 02243005 · BAYER INC
Health Canada status: MARKETED
What is MIRENA?
MIRENA 52 MG contains LEVONORGESTREL : 52 MG. It is listed in the Health Canada Drug Product Database under DIN 02243005, held by BAYER INC, supplied as INSERT (EXTENDED-RELEASE) for INTRAUTERINE administration. Health Canada currently lists it as marketed, status dated 22-Nov-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MIRENA used for?
Conception control for up to 8 years; treatment of idiopathic menorrhagia for up to 5 years in individuals accepting the contraceptive effect.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02243005 |
|---|---|
| Brand name | MIRENA |
| Generic / active ingredient | LEVONORGESTREL : 52 MG |
| Manufacturer | BAYER INC |
| Strength | 52 MG |
| Dosage form | INSERT (EXTENDED-RELEASE) |
| Route of administration | INTRAUTERINE |
| Schedule | Prescription |
| ATC code | G02BA03 PLASTIC IUD WITH PROGESTOGENS |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 22-Nov-2007 |
How is it administered?
Inserted into the uterine cavity by a healthcare professional. Effective for up to 8 years for contraception and 5 years for idiopathic menorrhagia. Follow specific aseptic insertion instructions.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text snippet (refer to section 11 of full monograph). Standard instructions: Do not use after expiry date.
How is it supplied?
Supplied in a sterile package with an inserter and a reminder card. Sterilized with ethylene oxide. Single use only.
Contraindications
Pregnancy, pelvic inflammatory disease, lower genital tract infection, postpartum endometritis, undiagnosed uterine bleeding, uterine anomalies/fibroids, malignancies, liver disease, endocarditis.
Warnings and precautions
Does not protect against STIs/HIV. Smoking increases cardiovascular risk. Risk of uterine perforation and expulsion. Clinical examination required before and after insertion.
What can be used instead?
Other Canadian products sharing ATC code G02BA03 PLASTIC IUD WITH PROGESTOGENS. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| KYLEENA | 19.5 MG | INSERT (EXTENDED-RELEASE) | BAYER INC | MARKETED | DIN 02459523 |
| JAYDESS | 13.5 MG | INSERT (EXTENDED-RELEASE) | BAYER INC | CANCELLED POST MARKET | DIN 02408295 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.